FDA Label for Mucus Relief

View Indications, Usage & Precautions

Mucus Relief Product Label

The following document was submitted to the FDA by the labeler of this product Spirit Pharmaceuticals Llc. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.

Drug Facts




Active Ingredient (In Each Tablet)



Guaifenesin 400 mg


Purpose



Expectorant


Uses



• helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive


Warnings



Do not use for children under 12 years of age


Ask A Doctor Before Use If You Have



• with persistent or chronic cough such as occurs with smoking,
asthma, chronic bronchitis, or emphysema • cough accompanied by


Stop Use And Ask A Doctor



if cough lasts more than 7 days, comes back, or occurs with fever, rash, or persistent headache. These could be signs of a serious illness.


If Pregnant Or Breast-Feeding,



ask a health professional before use.


Keep Out Of Reach Of Children.



In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)


Directions



• do not crush, chew, or break tablet • take with a full glass of water • adults and children 12 years of age and over: take 1 tablet every 4 hours with a full glass of water while symptoms persist. Do not exceed 6 tablets in 24 hours. • children under 12 years of age: do not use


Other Information



• store between 20-25°C (68-77°F)


Inactive Ingredients



Colloidal silicon dioxide, magnesium stearate, maltodextrin, microcrystalline cellulose, polyvinyl pyrrolidone, sodium starch glycolate, stearic acid


Questions Or Comments?



1-888-333-9792


Distributed By:



Cabinet Health P.B.C.


* Please review the disclaimer below.